Lv1
10 积分 2024-10-14 加入
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery
6个月前
已完结
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer
6个月前
已完结
A prospective comparison of resectability scores to enhance preoperative decision-making in the primary management of advanced ovarian cancer: a Memorial Sloan Kettering Cancer Center Team Ovary study
6个月前
已关闭
Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers
6个月前
已完结
Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis
6个月前
已完结
Neoadjuvant Therapy in Ovarian Cancer: Emerging Paradigms and Therapeutic Frontiers
6个月前
已完结
Ovarian cancer
7个月前
已完结
Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer
8个月前
已完结
Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer
8个月前
已完结
Relationship between ascites volume and clinical outcomes in epithelial ovarian cancer
8个月前
已完结
皖公网安备34019202002308
